Dr Reddy’s Labs - US/India Drive Earnings Growth
Motilal Oswal's research report onDr Reddy’s Labs Dr.Reddy’s Lab (DRRD) delivered 4QFY24 revenue in line with our estimate.
331 Views
Lupin - Niche Product Drives Earnings Growth
Motilal Oswal's research report onLupin Lupin (LPC) delivered in-line operational performance in 4QFY24. LPC ended FY24 on a strong note, with...
322 Views
IRB Infrastructure - In-Line Performance; Order Pipeline Remains Robust
Motilal Oswal's research report onIRB Infrastructure IRB Infrastructure (IRB)’s revenue grew 27% YoY to INR20.6b in 4QFY24 (in line).
327 Views
MAX Financial Services - Steady Performance; VNB Margin Beats Our Estimate
Motilal Oswal's research report onMAX Financial Services Gross written premium grew 17.3% YoY (in line) in 4QFY24. The renewal premium grew 15% YoY...
321 Views
Navin Fluorine International - Strong Performance Led by Specialty and HPP Businesses
Motilal Oswal's research report onNavin Fluorine International Navin Fluorine’s (NFIL) EBITDA/PAT grew 13%/42% YoY in 4QFY24, higher than our...
321 Views